{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:13:29Z","timestamp":1772558009081,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128265","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:17:32Z","timestamp":1769044652000},"page":"128265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adherence to national vaccination guidelines among pediatric cancer patients: a retrospective study from two tertiary care centers in Switzerland"],"prefix":"10.1016","volume":"75","author":[{"given":"Florence Anne","family":"Barbey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Otth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Drozdov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2026.128265_bb0005","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/1097-0142(19920315)69:6<1481::AID-CNCR2820690628>3.0.CO;2-L","article-title":"Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia","volume":"69","author":"Alanko","year":"1992","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128265_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/08880019409141671","article-title":"Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia","volume":"11","author":"Alanko","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128265_bb0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00043426-199809000-00008","article-title":"Immune recovery in children with malignancy after cessation of chemotherapy","volume":"20","author":"Mustafa","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128265_bb0020","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","article-title":"Lymphocyte depletion during treatment with intensive chemotherapy for cancer","volume":"84","author":"Mackall","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128265_bb0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cncr.20384","article-title":"Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy","volume":"101","author":"Zignol","year":"2004","journal-title":"Cancer"},{"issue":"27","key":"10.1016\/j.vaccine.2026.128265_bb0030","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1016\/j.vaccine.2014.04.042","article-title":"Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer","volume":"32","author":"Bochennek","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128265_bb0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1086\/514661","article-title":"Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia","volume":"27","author":"Feldman","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128265_bb0040","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1542\/peds.2007-1510","article-title":"Risks of invasive pneumococcal disease in children with underlying chronic diseases","volume":"122","author":"Hjuler","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128265_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.2007.06601.x","article-title":"Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia","volume":"137","author":"Meisel","year":"2007","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128265_bb0050","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.21203","article-title":"Epidemiology and outcomes of serious influenza-related infections in the cancer population","volume":"104","author":"Cooksley","year":"2005","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128265_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2026.128265_bb0060","article-title":"Increased risk of herpes zoster in children with cancer: a nationwide population-based cohort study","volume":"95","author":"Lin","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128265_bb0065","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","article-title":"Severe measles in immunocompromised patients","volume":"267","author":"Kaplan","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128265_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102646","article-title":"Human papillomavirus-associated subsequent malignant neoplasms among childhood cancer survivors","volume":"92","author":"Jia","year":"2024","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128265_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070349","article-title":"Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers","volume":"8","author":"Ojha","year":"2013","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128265_bb0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.mph.0000163214.37147.5a","article-title":"Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia","volume":"27","author":"Ercan","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128265_bb0085","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/pbc.22135","article-title":"Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination","volume":"53","author":"Zengin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128265_bb0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/511636","article-title":"Revaccination of children after completion of standard chemotherapy for acute leukemia","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128265_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/tropej\/49.5.286","article-title":"Immune deficiencies following cancer treatment in children","volume":"49","author":"Kantar","year":"2003","journal-title":"J Trop Pediatr"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128265_bb0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00043426-200411000-00008","article-title":"Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b","volume":"26","author":"Ek","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128265_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/pbc.26187","article-title":"Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia","volume":"64","author":"De de la Fuente Garcia","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128265_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1935169","article-title":"Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review","volume":"18","author":"MacDonald","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128265_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.993811","article-title":"Vaccination completeness in children with rheumatic diseases: a longitudinal, observational multicenter cohort study in Switzerland","volume":"10","author":"Welzel","year":"2022","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128265_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28565","article-title":"Vaccination in pediatric cancer survivors: vaccination rates, immune status, and knowledge regarding compliance","volume":"67","author":"Choi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"31","key":"10.1016\/j.vaccine.2026.128265_bb0125","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2017.74.1843","article-title":"Human papillomavirus vaccination rates in young cancer survivors","volume":"35","author":"Klosky","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128265_bb0130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s11764-019-00791-9","article-title":"Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer","volume":"13","author":"Castellino","year":"2019","journal-title":"J Cancer Surviv"},{"issue":"24","key":"10.1016\/j.vaccine.2026.128265_bb0135","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1016\/j.vaccine.2006.03.059","article-title":"Influenza vaccination coverage among children with high-risk medical conditions","volume":"24","author":"Esposito","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128265_bb0140","first-page":"3815","article-title":"Vaccination against influenza at a European pediatric cancer center: immunization rates and attitudes among staff, patients, and their families","volume":"25","author":"Pettke","year":"2017","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128265_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pbc.22256","article-title":"Survivors of childhood cancer: an Australian audit of vaccination status after treatment","volume":"54","author":"Crawford","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128265_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eimc.2016.09.003","article-title":"Adapting immunisation schedules for children undergoing chemotherapy","volume":"36","author":"Fern\u00e1ndez-Prada","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.vaccine.2026.128265_bb0155","unstructured":"Bundesamt f\u00fcr Gesundheit (BAG), Eidgen\u00f6ssische Kommission f\u00fcr Impffragen (EKIF). Empfehlung zur Impfung von Personen mit malignen Erkrankungen und deren Haushaltskontakte. BAG-Bulletin 2022;20:20\u201330. PDF. https:\/\/backend.bag.admin.ch\/fileservice\/sdweb-docs-prod-bagadminch-files\/files\/2025\/03\/18\/f4a7773d-c8cb-45af-aefa-5986d6a41f0f.pdf [accessed 14 Nov 2025]."},{"key":"10.1016\/j.vaccine.2026.128265_bb0160","unstructured":"Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: Version 6.0. Monrovia (CA): Children's Oncology Group; 2023. Available from: https:\/\/www.survivorshipguidelines.org\/ [accessed 30 Dec 2025]."},{"issue":"2","key":"10.1016\/j.vaccine.2026.128265_bb0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2026.128265_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"#cr-split#-10.1016\/j.vaccine.2026.128265_bb0175.1","unstructured":"Bundesamt f\u00fcr Gesundheit (BAG). BAG-Bulletin 13 vom 25. M\u00e4rz 2024: Durchimpfung von 2-, 8- und 16-j\u00e4hrigen Kindern und Jugendlichen in der Schweiz, 2020-2022. Bern: Bundesamt f\u00fcr Gesundheit"},{"key":"#cr-split#-10.1016\/j.vaccine.2026.128265_bb0175.2","unstructured":"2024. https:\/\/www.bag.admin.ch\/dam\/de\/sd-web\/XW9RQECXiyCA\/bu-13-24.pdf [accessed 14 Nov 2025]."},{"issue":"9","key":"10.1016\/j.vaccine.2026.128265_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27268","article-title":"A multiyear quality improvement project to increase influenza vaccination in a pediatric oncology population undergoing active therapy","volume":"65","author":"Olshefski","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128265_bb0185","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2014-0943","article-title":"Quality improvement initiative to increase influenza vaccination in pediatric cancer patients","volume":"135","author":"Freedman","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128265_bb0190","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/vaccines11030703","article-title":"Adherence to vaccines in adult patients with immune-mediated inflammatory diseases: a two-year prospective Portuguese cohort study","volume":"11","author":"Abreu","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128265_bb0195","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1080\/21645515.2020.1763739","article-title":"Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups","volume":"16","author":"Boey","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128265_bb0200","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/vaccines8030480","article-title":"Determinants of vaccination uptake in risk populations: a comprehensive literature review","volume":"8","author":"Doornekamp","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128265_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1440-1754.2007.01162.x","article-title":"Immunisation practices of paediatric oncologists: an Australasian survey","volume":"43","author":"Crawford","year":"2007","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128265_bb0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/mpo.10152","article-title":"Survey of immunisation practices in the United Kingdom during and following completion of anti-cancer chemotherapy in children","volume":"40","author":"Mahajan","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.vaccine.2026.128265_bb0215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jpeds.2020.07.038","article-title":"Barriers to pretransplant immunization: a qualitative interview study of pediatric solid organ transplant stakeholders","volume":"227","author":"Feldman","year":"2020","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128265_bb0220","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.2010.08522.x","article-title":"Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules","volume":"152","author":"Lehrnbecher","year":"2011","journal-title":"Br J Haematol"},{"issue":"10500","key":"10.1016\/j.vaccine.2026.128265_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(25)01037-2","article-title":"Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128265_bb0230","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.57187\/s.4525","article-title":"Impact of the COVID-19 pandemic on routine childhood immunisation coverage and timeliness in Switzerland: a retrospective analysis using data from the Swiss National Vaccination Coverage Survey, 2019\u20132023","volume":"155","author":"Baroutsou","year":"2025","journal-title":"Swiss Med Wkly"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:47:40Z","timestamp":1772552860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"alternative-id":["S0264410X26000721"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128265","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to national vaccination guidelines among pediatric cancer patients: a retrospective study from two tertiary care centers in Switzerland","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128265"}}